82P NEXUS: A phase I dose escalation study of selinexor plus nivolumab and ipilimumab in Asian patients with advanced/metastatic solid malignancies

Category Primary study
JournalAnnals of Oncology
Year 2023
This article has no abstract
Epistemonikos ID: 9ec6b4b77d9f87da8313e394f971f8147d55b2f1
First added on: Feb 18, 2025